Zylox

About:

Zylox is an interventional and implantable peripheral vascular device developer.

Website: http://www.zyloxmedical.com/

Top Investors: OrbiMed, BioVenture, Highlight Capital, SDIC Fund Management, Octagon Capital Advisors

Description:

Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson & Johnson, Medtronic, and Abbott before returning to China. Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices.

Total Funding Amount:

$66.8M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2012-01-01

Contact Email:

info(AT)zyloxmedical.com

Founders:

Zhong "Jonathon" Zhao

Number of Employees:

501-1000

Last Funding Date:

2020-10-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai